New evidence–based clinical practice guidelines from the Alzheimer’s Association provide updated recommendations on evaluating individuals suspected of having Alzheimer’s disease (AD) and AD ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...
Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.